These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15487332)

  • 1. Meeting report: Candida and Candidiasis.
    Sturtevant J
    Mycopathologia; 2004 Jul; 158(1):141-6. PubMed ID: 15487332
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Typing and Antifungal Susceptibility of Candida viswanathii, India.
    Shankarnarayan SA; Rudramurthy SM; Chakrabarti A; Shaw D; Paul S; Sethuraman N; Kaur H; Ghosh AK
    Emerg Infect Dis; 2018 Oct; 24(10):1956-1958. PubMed ID: 30226183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal resistance: an emerging battlefield.
    Woo PC; Tsang CC; Lau SK
    Future Microbiol; 2020 May; 15():571-574. PubMed ID: 32484001
    [No Abstract]   [Full Text] [Related]  

  • 4. 8th ASM conference on Candida and candidiasis: molecular tools provide insights into host-pathogen interactions.
    Moran GP; Jabra-Rizk MA
    Mycopathologia; 2006 Jul; 162(1):17-24. PubMed ID: 16830187
    [No Abstract]   [Full Text] [Related]  

  • 5. [CANDIDIASIS GASTROINTESTINAL TRACT].
    Kozlova IV; Lekareva LI; Bykova AP; Myalina JN; Ostrovskàja LJ
    Eksp Klin Gastroenterol; 2016; (3):40-6. PubMed ID: 27333619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertebral osteomyelitis due to Candida parapsilosis in a child with Crohn disease while receiving anti-TNF therapy.
    Huang A; Huang C; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):e23-6. PubMed ID: 23201701
    [No Abstract]   [Full Text] [Related]  

  • 7. The diverse genomes of Candida auris.
    Gifford H; Rhodes J; Farrer RA
    Lancet Microbe; 2024 Sep; 5(9):100903. PubMed ID: 38889739
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifungal drug resistance of pathogenic fungi.
    Kontoyiannis DP; Lewis RE
    Lancet; 2002 Mar; 359(9312):1135-44. PubMed ID: 11943280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: A 10-year study.
    Sasso M; Roger C; Sasso M; Poujol H; Barbar S; Lefrant JY; Lachaud L
    Mycoses; 2017 Dec; 60(12):770-780. PubMed ID: 28758337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy: a potential adjunctive treatment for fungal infection.
    Kullberg BJ; van de Veerdonk F; Netea MG
    Curr Opin Infect Dis; 2014 Dec; 27(6):511-6. PubMed ID: 25304393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases.
    Krcmery V; Demitrovicova A; Kisac P
    J Chemother; 2011 Oct; 23(5):310-1. PubMed ID: 22005067
    [No Abstract]   [Full Text] [Related]  

  • 12. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris.
    Chatterjee S; Alampalli SV; Nageshan RK; Chettiar ST; Joshi S; Tatu US
    BMC Genomics; 2015 Sep; 16(1):686. PubMed ID: 26346253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Detection of Resistance to Echinocandins.
    Posteraro B; Vella A; De Carolis E; Sanguinetti M
    Methods Mol Biol; 2017; 1508():413-421. PubMed ID: 27837518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of resistant Candida species in cancer centers: implications for treatment and prophylaxis.
    Riddell J; Kauffman CA
    Cancer; 2008 Jun; 112(11):2334-7. PubMed ID: 18412152
    [No Abstract]   [Full Text] [Related]  

  • 15. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.
    Baily GG; Moore CB; Essayag SM; de Wit S; Burnie JP; Denning DW
    Clin Infect Dis; 1997 Jul; 25(1):161-3. PubMed ID: 9243058
    [No Abstract]   [Full Text] [Related]  

  • 16. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes.
    Ruan SY; Kuo YW; Huang CT; Hsiue HC; Hsueh PR
    Int J Antimicrob Agents; 2010 Jan; 35(1):85-8. PubMed ID: 19786341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.
    Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
    FEMS Microbiol Rev; 2012 Mar; 36(2):288-305. PubMed ID: 21569057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of candidiasis: insights from host genetics.
    Delsing CE; Bleeker-Rovers CP; Kullberg BJ; Netea MG
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):947-56. PubMed ID: 23030333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Candida tropicalis resistant to caspofungin.
    Pasquale T; Tomada JR; Ghannoun M; Dipersio J; Bonilla H
    J Antimicrob Chemother; 2008 Jan; 61(1):219. PubMed ID: 18024953
    [No Abstract]   [Full Text] [Related]  

  • 20. Triazole-resistant candidaemia following posaconazole exposure.
    Weiler S; Lass-Flörl C; Auberger J; Bellmann-Weiler R; Stein M; Joannidis M; Bellmann R
    Int J Antimicrob Agents; 2009 May; 33(5):494-5. PubMed ID: 19153033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.